Login
Ecolab Inc logo

Ecolab Inc

ecolab.com

Ecolab Inc (NYSE: ECL) is a water, hygiene, and infection prevention solutions company that sells chemical products, equipment, and related services to commercial and institutional customers. Revenue comes from two streams: product and equipment sales, and service and lease sales, both recognized on a transactional basis across its operating segments. The filing reflects operations across multiple reportable segments with both domestic and international exposure, including sales denominated in foreign currencies that are reported at fixed and public currency rates. The 10-K filed February 23, 2026 (accession 0001104659-26-018357) covers fiscal year 2025. Ecolab carries long-term debt on its balance sheet, issued $1,045.6 million in long-term borrowings in FY2025 while repaying $674.2 million, and deployed $2,707.2 million in investing activities during the same period, a significant increase from $433.8 million in FY2024, consistent with acquisition activity. The company pays dividends and has noncontrolling interest in certain subsidiaries.

Products & Services

Products include chemical formulations sold to commercial customers. Equipment sales and lease arrangements accompany chemical programs. Service revenue covers field service and application support tied to those programs.

Revenue Model

Transactional revenue from product and equipment sales and from service and lease arrangements. Both revenue streams have corresponding cost-of-sales line items disclosed separately in the income statement.

Customers & Markets

The filing does not specify customer names, concentration percentages, or end-market breakdowns in the excerpts provided.

Geographic Exposure

Operations span domestic and international markets. Foreign currency translation had a 2% positive impact on public currency sales change in FY2025, indicating material non-U.S. revenue. Specific country or regional revenue splits are not supported by the excerpts provided.

Financial Snapshot

Revenue
TTM
$16.84B
Gross Margin
TTM
44.16%
Net Income
TTM
$2.116B
Current Assets
2026 Q2
$11.02B
Current Liabilities
2026 Q2
$5.987B
Current Ratio
2026 Q2
184.07%
Total Assets
2026 Q2
$29.93B
Total Liabilities
2026 Q2
$19.87B
Book Value
2026 Q2
10.06B
Cash
2026 Q2
$5.135B
P/E
TTM
36.92
Free Cash Flow
TTM
$1.385B

Stock Price

Loading...
Market Cap: $78.135 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support